EGFR抑制剂
| 英文名 | PD168393 | CAS号 | 194423-15-9 |
| 试剂别名 |
PD 168393;N-[4-(3-bromoanilino)quinazolin-6-yl]prop-2-enamide;N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-propenamide;4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline;AC1L1IRY;AC1Q26CC;N-(4-(3-bromophenylamino)quinazoline-6-yl)acrylamide;N-[4-[(3-bromophenyl)-amino]-quinazolin-6-yl]-acrylamide;N-[4-[(3-Bromophenyl)amino]quinazolin-6-yl]-acrylamide;n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}prop-2-enamide;nchembio866-comp2;PD-168393;SureCN2680536;4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline; N-[4-[(3-Bromophenyl)amino]-6-quinazolinyl]-2-propenamide;4-[(3-BROMOPHENYL)AMINO]-6-ACRYLAMIDOQUINAZOLINE;N-(4-((3-Bromophenyl)amino)quinazolin-6-yl)acrylamide;N-[4-[(3-Bromophenyl)amino]-6-quinazolinyl]-2-propenamide;2-Propenamide, N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-
|
分子式 | C17H13BrN4O |
| 产品编号 | APEA2024 | 分子量 | 369.22 |
| MDL号 | MFCD02179207 |
| 产品名称： | EGFR抑制剂 |
| 英文名称： | PD168393 |
| 英文别名： | PD 168393;N-[4-(3-bromoanilino)quinazolin-6-yl]prop-2-enamide;N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-propenamide;4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline;AC1L1IRY;AC1Q26CC;N-(4-(3-bromophenylamino)quinazoline-6-yl)acrylamide;N-[4-[(3-bromophenyl)-amino]-quinazolin-6-yl]-acrylamide;N-[4-[(3-Bromophenyl)amino]quinazolin-6-yl]-acrylamide;n-{4-[(3-bromophenyl)amino]quinazolin-6-yl}prop-2-enamide;nchembio866-comp2;PD-168393;SureCN2680536;4-[(3-Bromophenyl)amino]-6-acrylamidoquinazoline; N-[4-[(3-Bromophenyl)amino]-6-quinazolinyl]-2-propenamide;4-[(3-BROMOPHENYL)AMINO]-6-ACRYLAMIDOQUINAZOLINE;N-(4-((3-Bromophenyl)amino)quinazolin-6-yl)acrylamide;N-[4-[(3-Bromophenyl)amino]-6-quinazolinyl]-2-propenamide;2-Propenamide, N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]- |
| 中文别名： | N-[4-[(3-溴苯基)氨基]-6-喹唑啉]-2-丙酰胺;N-[4-[(3-溴苯基)氨基]-6-喹唑啉基]-2-丙烯酰胺 |
| CAS No.： | 194423-15-9 |
| 分子式： | C17H13BRN4O |
| 分子量： | 369.22 |
| 危险品级别： | |
| HS符号： | |
| 危害声明： |
